Global Cervical Cancer Treatment Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 8.23 Million |
 Market Size (Forecast Year) |
USD 12.63 Million |
 CAGR |
% |
| Major Markets Players |
>全球宫颈癌治疗市场，按类型（鳞状细胞癌、腺癌）、产品（预防、治疗）、治疗（手术、放疗、化疗、免疫疗法）、给药途径（口服、肠外、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2030 年。
宫颈癌治疗市场分析及规模
宫颈癌的死亡率约为 50%，但可通过诊断和预防将死亡率降至最低。由于疾病进展通常较慢，癌前病变为预防和治疗提供了可能性。由于缺乏认识或无法获得诊断设施，大多数病例都是在疾病进展的后期才出现的。人乳头瘤病毒 (HPV) 是宫颈癌的主要致病因素，通常通过性传播获得。HPV 有 100 多种菌株，其中 13 种是高风险或致癌的。
Data Bridge Market Research 分析了 2023-2030 年预测期内宫颈癌治疗市场的增长率。间皮瘤治疗市场的预期复合年增长率在上述预测期内趋于 5.5% 左右。2022 年市场价值为 823 万美元，到 2030 年将增长至 1263 万美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
宫颈癌治疗市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（鳞状细胞癌、腺癌）、产品（预防、治疗）、治疗（手术、放疗、化疗、免疫疗法）、给药途径（口服、肠胃外、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited(Mumbai), Sanofi S.A.( France), CLOVIS ONCOLOGY (U.S.), Bayer AG (Germany), Lilly (U.S.), Merck & Co., Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AbbVie Inc. (U.S.), Vivesto AB (Sweden), Alnylam Pharmaceuticals, Inc (U.S.), Biocon (India), Genentech, Inc (U.S.), Hetero (India) |
|
Market Opportunities |
|
Market Definition
Cervical cancer is the cancer that appears in the form of tumour formation in cervix cells. Numerous strains of human papillomavirus (HPV), sexually transmitted agent that can cause infection are responsible for generating the cervical cancer. Cervical cancer initiates when healthy cells of the cervix develop changes (mutations) in their DNAs.
Global Cervical Cancer Treatment Market Dynamics
Drivers
- Availability of Vaccines
There has been a wide availability of vaccines that have been launched to improve the patient’s recovery process. For instance, Gardasil led the preventive vaccine segment in 2017, supported by strong commercial sales globally. In addition, the FDA approved Gardasil 9, an improvised, nonavalent version of Gardasil, in 2015. This label expansion gave Gardasil and Gardasil 9 a distinct clinical advantage over Cervarix. Thus, this factor enhances the market growth.
- Increasing Demand for Targeted Therapy
The increasing demand for targeted therapy showed many advantages as it interferes with specific proteins involved in tumorigenesis, focusing on specific molecular changes that stop the growth of numerous cancers. Several significant factors influenced the growth of gynecology cancer, including the fewer adverse effects of the therapy and the availability of several targeted therapeutics. This boosts the market growth.
Opportunities
- Growing Adoption of Biologics
There has been a growing adoption of biologics, creating many market growth opportunities. For instance, Avastin (bevacizumab) was approved for the treatment of cervical cancer in 2014. Avastin was approved in Europe and Japan in 2015 and 2016, respectively. Besides this, the FDA approved Keytruda in 2018. Although generic products continue to capture major market share, the arrival of biologics and other targeted therapies show a substantial shift in this therapeutic space through the forecast period.
- Increasing Demand for Online Pharmacies
Online pharmacies segment is projected to be the fastest-growing distribution channel segment. This growth can be due to its user-friendly interfaces and convenience in terms of access, prices, and delivery. In addition, they offer numerous discounts on purchasing a certain amount or bundle pricing for cancer products.
Restraints/Challenges
- Side Effects of Chemotherapy
There are various side effects that are associated with chemotherapy. Effects such as nausea and vomiting, hair loss, and mouth sores decrease market growth.
- High Cost
The huge expenditure associated with these agents hamper the market growth. The high treatment costs and the prices of several medications including biologics hinder the market growth.
This cervical cancer treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cervical cancer treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Cervical Cancer Treatment Market Scope
The cervical cancer treatment market is segmented on the basis of type, product, treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Squamous Cell Carcinoma
- Adenocarcinoma
Product
- Prevention
- Gardasil/Gardasil9
- Cervarix
- Treatment
- Avastin
- Keytruda
- Generics
- Others
Treatment Type
- Surgery
- Radiation
- Chemotherapy
- Immunotherapy
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Cervical Cancer Treatment Market Regional Analysis/Insights
The cervical cancer treatment market is analyzed and market size insights and trends are provided by type, product, treatment type, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the cervical cancer treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for cervical cancer treatment market throughout the forecasted period due to increased demand of cost-effective treatment solutions.
North America dominates the market due to the increased technological developments of the product, high research and development, healthcare expenditure, and skilled professionals.
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球宫颈癌治疗市场份额分析
宫颈癌治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球宫颈癌治疗市场的关注有关。
宫颈癌治疗市场的主要参与者包括：
- 强生私人有限公司（美国）
- Mylan NV（美国）
- 太阳制药工业有限公司（印度）
- 赛诺菲法国
- 克洛维斯肿瘤学（美国）
- 拜耳公司（德国）
- 礼来（美国）
- 默克公司（美国）
- 葛兰素史克公司 (英国)
- 诺华公司（瑞士）
- AbbVie Inc.（美国）
- Vivesto AB（瑞典）
- Alnylam Pharmaceuticals, Inc（美国）
- Biocon（印度）
- 基因泰克公司（美国）
- 异性恋（印度）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
